Results (22)
DARWIN EU® Drug utilization study of prescription opioids
Belgium
Estonia
Finland
France
Germany
Netherlands
Spain
EU PAS number:
EUPAS105641
First published:
23/04/2024
StudyOngoing
DARWIN EU® Prevalence of rare blood cancers in Europe
Belgium
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS50800
First published:
23/04/2024
StudyFinalised
DARWIN EU® Characterization of patients with chronic hepatitis B and C
Estonia
France
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS107650
First published:
21/03/2024
StudyOngoing
DARWIN EU® - Use of take-home naloxone for opioid overdose treatment
Belgium
Germany
Spain
United Kingdom
EU PAS number:
EUPAS105644
First published:
23/04/2024
StudyOngoing
DARWIN EU® Monitoring prescription of essential medicines administered in ICU
France
Portugal
Spain
EU PAS number:
EUPAS1000000089
First published:
27/03/2024
StudyOngoing
DARWIN EU® Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000080
First published:
03/05/2024
StudyOngoing
DARWIN EU® Age specific incidence rates of RSV related disease in Europe
Estonia
France
Germany
Spain
United Kingdom
EU PAS number:
EUPAS107708
First published:
23/04/2024
StudyOngoing
DARWIN EU® Multiple myeloma: patient characterisation, treatments and survival in the period 2012-2022
Estonia
Finland
France
Germany
Netherlands
Spain
EU PAS number:
EUPAS105033
First published:
23/04/2024
StudyOngoing
DARWIN EU® Drug utilisation of valproate-containing medicinal products in women of childbearing potential
Belgium
Finland
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS50789
First published:
02/04/2024
StudyFinalised
DARWIN EU® Monitoring prescription of medicines for public health emergencies at risk of shortages
Belgium
Germany
Spain
United Kingdom
EU PAS number:
EUPAS107932
First published:
21/03/2024
StudyOngoing
DARWIN EU® – Frailty and polypharmacy among adults with selected cancers at the time of diagnosis
Belgium
Estonia
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000120
First published:
02/05/2024
StudyPlanned
DARWIN EU® Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations
Estonia
France
Germany
Spain
United Kingdom
EU PAS number:
EUPAS107454
First published:
25/03/2024
StudyOngoing
DARWIN EU® Rates of occurrence of treatment-related intercurrent events in patients with major depressive disorder
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS106685
First published:
21/03/2024
StudyOngoing
DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus
France
Germany
Spain
United Kingdom
EU PAS number:
EUPAS106436
First published:
23/04/2024
StudyOngoing
DARWIN EU® Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000088
First published:
27/03/2024
StudyOngoing
DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis
Belgium
France
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS106798
First published:
21/03/2024
StudyOngoing
DARWIN EU® Effectiveness of COVID 19 vaccines on severe COVID 19 and post acute outcomes of SARS CoV 2 infection
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS107615
First published:
02/04/2024
StudyOngoing
DARWIN EU® CC - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)
Estonia
France
Germany
United Kingdom
EU PAS number:
EUPAS106052
First published:
06/03/2024
StudyOngoing
DARWIN EU® DUS of Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
France
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS103381
First published:
21/03/2024
StudyFinalised
DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment
France
Netherlands
Spain
EU PAS number:
EUPAS1000000112
First published:
30/04/2024
StudyOngoing
DARWIN EU® EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant
Estonia
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS106679
First published:
21/03/2024
StudyOngoing
DARWIN EU® - Background rates of serious adverse events to contextualise safety assessments in clinical trials and non-interventional studies in adolescent and adult patients with severe asthma
Estonia
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS103936
First published:
23/04/2024
StudyOngoing